| HOME >> MEDICINE >> TECHNOLOGY |
1,247,230$
1,669,387 Restricted cash794,115- Accounts and notes receivable, net18,076,05011,531,027 Other receivables, net4,084,1024,111,315 Advances to suppliers, net542,153580,168 Inventories2,695,3882,599,351 Amounts due from related parties574,899190,614 Current deferred tax assets1,394,101833,568 Other current assets199,929208,111Total current assets29,607,96721,723,541 Property, plant and equipment, net 25,873,67021,069,139 Intangible assets, net 1,473,0741,432,736 Deposits for long-live assets1,078,846754,979 Non-current deferred tax assets275,677366,478Total assets$
58,309,234$
45,346,873CHINA SHENGHUO PHARMACEUTICAL HOLDINGS, INC. AND SUBSIDIARIESCONSOLIDATED BALANCE SHEETS (CONT'D)(Amounts in USD, except shares)December 31,20112010Liabilities and Equity:Current liabilities: Accounts payable$9,395,483
$
8,964,404 Other payables and accrued expenses11,819,1799,699,857 Sales representative deposits6,106,2874,936,429 Amounts due to related parties18,41479,864 Short-term borrowings15,858,8955,289,178 Advances from customers1,090,6681,158,649 Taxes and related payables2,255,322881,506 Current portion of long-term borrowings6,253,0756,039,833Total current liabilities52,797,32337,049,720Long-term borrowings-6,251,227Total liabilities52,797,32343,300,947Commitments and ContingenciesEquity: Common stock, $0.0001 par value, 100,000,000 sharesauthorized and 19,679,400 shares issued and outstanding1,9681,968 Additional paid-in capital6,014,6886,193,927 Appropriated retained earnings147,023147,023 Accumulated deficit(5,790,759)(5,940,439) Accumulated other comprehensive income1,743,3931,638,109Total stockholder's equity2,116,3132,040,588Non-controlling interest3,395,5
'/>"/>
| SOURCE China Shenghuo Pharmaceutical Copyright©2010 PR Newswire. All rights reserved |